BridgeMD
New treatment option for Behavioral Intervention
Official title Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial
ClinicalTrials.gov ID: NCT07125235
What this study is testing
- What it's testing
- Men who are living with HIV and use stimulants face many challenges and barriers that may interfere with remembering to take their HIV medication. Forgetting to take HIV medication puts men living with HIV at a greater risk of becoming virally unsuppressed.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70, men only
You may be able to join if
- Prescribed antiretroviral therapy (ART) with a tenofovir-based regimen.
- Documented virologic non-suppression, urine tenofovir testing without tenofovir detected, or self-reported adherence \<100%.
- Reports stimulant use.
- Has a mailing address within the U.S.
- Currently has a smartphone with photo capabilities.
You likely can't join if
- Have any health condition that may interfere with participation or the ability to provide informed consent, including any debilitating or...
- Not prescribed ART.
- Unwilling to perform urine self-testing or to attend a local Quest site for viral load monitoring.
- Unable to provide a hair sample of \~50-100 strands of hair that are non-gray, not bleached, and at least 1cm in length
The study team makes the final eligibility decision.
Where it's taking place
- San Francisco, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Francisco, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.